Market penetration of new drugs in one United Kingdom region : implications for general practitioners and administrators.
To determine the use of new drugs in one United Kingdom region.
Design-Examination of data on prescribing of angiotensin converting enzyme inhibitors, new broad spectrum antibiotics, and H2 receptor antagonists.
Calculation of number of defined daily doses prescribed each month.
Setting-All general practices in Northern Ireland.
Main outcome measures-Drug use index and market share of each drug.
During 1988-91 prescribing of angiotensin converting enzyme inhibitors increased by 126%, of H2 receptor antagonists by 46%, and of new antibiotics by 207%. The first drug on the market usually retained the largest market share.
Use of oral antibiotics increased threefold respective of the reporting policy of the general practitioners local laboratory.
Mots-clés Pascal : Traitement, Homme, Chimiothérapie, Grande Bretagne, Indication, Pénétration marché, Médecin, Médicament, Royaume Uni, Europe
Mots-clés Pascal anglais : Treatment, Human, Chemotherapy, Great Britain, Indication, Market penetration, Physician, Drug, United Kingdom, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0040556
Code Inist : 002B30A11. Création : 199406.